123 related articles for article (PubMed ID: 36976911)
21. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
[TBL] [Abstract][Full Text] [Related]
22. LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
Mezquita B; Pineda E; Mezquita J; Mezquita P; Pau M; Codony-Servat J; Martínez-Balibrea E; Mora C; Maurel J; Mezquita C
Mol Carcinog; 2016 May; 55(5):411-9. PubMed ID: 25647613
[TBL] [Abstract][Full Text] [Related]
23. Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells.
Lee HC; Ling QD; Yu WC; Hung CM; Kao TC; Huang YW; Higuchi A
Drug Des Devel Ther; 2013; 7():491-502. PubMed ID: 23818760
[TBL] [Abstract][Full Text] [Related]
24. An N
Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
[TBL] [Abstract][Full Text] [Related]
25. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
[TBL] [Abstract][Full Text] [Related]
26. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.
Almendro V; Ametller E; García-Recio S; Collazo O; Casas I; Augé JM; Maurel J; Gascón P
PLoS One; 2009; 4(3):e4728. PubMed ID: 19266094
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
28. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
29. Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells.
Park J; Lee GE; An HJ; Lee CJ; Cho ES; Kang HC; Lee JY; Lee HS; Choi JS; Kim DJ; Choi JS; Cho YY
Arch Pharm Res; 2021 Dec; 44(12):1091-1108. PubMed ID: 34750753
[TBL] [Abstract][Full Text] [Related]
30. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
31. Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer.
Pocard M; Debruyne P; Bras-Gonçalves R; Mareel M; Dutrillaux B; Poupon MF
Dis Colon Rectum; 2001 Aug; 44(8):1106-12. PubMed ID: 11535849
[TBL] [Abstract][Full Text] [Related]
32. The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.
Pirpour Tazehkand A; Akbarzadeh M; Velaie K; Sadeghi MR; Samadi N
Biomed Pharmacother; 2018 Jul; 103():755-766. PubMed ID: 29684854
[TBL] [Abstract][Full Text] [Related]
33. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
34. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.
Ametller E; García-Recio S; Pastor-Arroyo EM; Callejo G; Carbó N; Gascón P; Almendro V
Cancer Biol Ther; 2011 Jan; 11(1):4-13. PubMed ID: 20980803
[TBL] [Abstract][Full Text] [Related]
36. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
[TBL] [Abstract][Full Text] [Related]
37. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
Yang H; He L; Kruk P; Nicosia SV; Cheng JQ
Int J Cancer; 2006 Nov; 119(10):2304-12. PubMed ID: 16894566
[TBL] [Abstract][Full Text] [Related]
38. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
[TBL] [Abstract][Full Text] [Related]
40. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
